Replies to post #19898 on Synaptogenix Inc (SNPX)

[sstyles]

i think the two other failed trials have folks not convinced......we are in prove it mode now....

it's like how many times can you spin a failed study.

[Battle Ready]

SPNX is currently trading close to tangible cash with a low burn rate, multiple indications in play and a potentially "miraculous" drug that wouldn't have a value ceiling...

The recent peer reviewed analysis suggests a statistically credible chance at success with the current trial design. The market has valued substantially less that what success in this trial would suggest, at $20+ billion...

So, pick a number??? Would it be stupid for this company to be currently trading at 10x the current price, $67/share, NO, not in the least, it would still offer tremendous upside and be a better risk/reward speculative play than most others in this space, IMHO...